Summary:
- ABM Respiratory Care, a medical technology company based in Eagan, MN, secured $14.8M in Series B funding led by Peter Soderberg.
- The funding will be utilized to expedite the commercialization of BiWaze Clear, an innovative airway clearance system for hospital and home use.
- ABM Respiratory Care, under the leadership of CEO Greg Miller, aims to enhance patient care by developing advanced respiratory solutions for improved breathing.
Article:
ABM Respiratory Care Raises $14.8M in Series B Funding
Accelerating Innovation in Respiratory Care
ABM Respiratory Care, a leading medical technology company, has successfully raised $14.8M in Series B funding, with Peter Soderberg at the forefront of the investment drive. This significant financial boost will propel the company’s latest development, BiWaze Clear, an advanced airway clearance system tailored for both hospital and home settings.
Empowering Better Breathing
With a focus on revolutionizing patient care, ABM Respiratory Care, spearheaded by CEO Greg Miller, is committed to pioneering intelligent and innovative respiratory solutions. BiWaze Clear stands out as a game-changer, offering a unique combination of lung expansion, high-frequency oscillations, and aerosol delivery to optimize lung health and mucus clearance. Its portable, battery-operated design ensures convenient use and enhances therapy efficiency.
Enhancing Respiratory Wellness
ABM Respiratory Care’s mission is to empower individuals to breathe better, both in and out of medical facilities. By leveraging cutting-edge technology and clinical expertise, the company is dedicated to improving respiratory wellness and enhancing quality of life. The recent funding injection will further drive the commercialization and availability of BiWaze Clear, marking a significant milestone in the advancement of respiratory care.
FinSMEs
17/06/2025
